S. 2236 (112th): Advancing Breakthrough Therapies for Patients Act of 2012

Introduced:

Mar 26, 2012
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on March 26, 2012, in a previous session of Congress, but was not enacted.

Sponsor:

Michael Bennet

Senior Senator from Colorado

Democrat

Text:

Read Text »
Last Updated: Mar 26, 2012
Length: 8 pages

About the bill

Full Title

A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Mar 26, 2012
 
Introduced

This is the first step in the legislative process.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: